ALFUZOSIN

sanis health inc🇨🇦 Health Canada

Approval Id: 31ffbe47be086707
Drug Approval Canada Name: ALFUZOSIN
Product Name: ALFUZOSIN
Status: Marketed
Status Date: 2022-02-24
Original Market Date: 2022-02-24
Din: 02519844
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 12:16.04.12
Atc Original: G04CA01 ALFUZOSIN
Atc Name: g 04 ca 01
Aig Number: 0146806001
Company Name: sanis health inc
Company Address: 1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5

ALFUZOSIN HYDROCHLORIDE

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

31ffbe47be086707

Type

Standard